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ABSTRACT There is a distinct possibility that general anesthetics exert their action on the postsynaptic receptor channels.
The structural requirements for anesthetic binding in transmembrane channels, however, are largely unknown. High-
resolution 1H nuclear magnetic resonance and direct photoaffinity labeling were used in this study to characterize the volatile
anesthetic binding sites in gramicidin A (gA) incorporated into sodium dodecyl sulfate (SDS) micelles and into dimyris-
toylphosphatidylcholine (DMPC) bilayers, respectively. To confirm that the structural arrangement of the peptide side chains
can affect anesthetic binding, gA in nonchannel forms in methanol was also analyzed. The addition of volatile anesthetic
halothane to gA in SDS with a channel conformation caused a concentration-dependent change in resonant frequencies of
the indole amide protons of W9, W11, W13, and W15, with the most profound changes in W9. These frequency changes were
observed only for gA carefully prepared to ensure a channel conformation and were absent for gA in methanol. For gA in
DMPC bilayers, direct [14C]halothane photolabeling and microsequencing demonstrated dominant labeling of W9, less
labeling of W11 and W13, and no significant labeling of W15. In methanol, gA showed much less labeling of any residues.
Inspection of the 3-D structure of gA suggests that the spatial arrangements of the tryptophan residues in the channel form
of gA, combined with the amphiphilic regions of lipid, create a favorable anesthetic binding motif.
INTRODUCTION
Sensitivity to general anesthetics has placed a superfamily
of ligand-gated ion channels at the top of the list of candi-
date sites for general anesthetic action. These include gly-
cine, -aminobutyric acid type A (GABAA), neuronal nic-
otinic acetylcholine (nACh), and 5-hydroxytryptamine type
3 (5-HT3) receptors. Although the functional characteristics
of these channels have been extensively studied (Eckenhoff
and Johansson, 1997; Dilger et al., 1997; Forman et al.,
1995; Franks and Lieb, 1994; Harrison et al., 1993; Jenkins
et al., 1996; Mihic et al., 1997), the anesthetic binding sites
at the molecular level have still not been revealed. The
difficulty is associated directly with the lack of structural
information about these complicated ion channels. Before a
3-D structure of these channels becomes available, it is
advantageous to use simplified and structurally well-char-
acterized membrane channels as models to analyze the
structural requirements for anesthetic binding in transmem-
brane channels. The characteristics of the binding site or
sites learned from the simplified models may possibly be
generalized to the authentic receptors.
Gramicidin A (gA) is a simple model of an ion channel
(Tang et al., 1999a,c; Cross, 1997; Laio and Torre, 1999;
Lundbaek and Andersen, 1999; Tian and Cross, 1999; Cot-
ten et al., 1997). It is one of the best-characterized trans-
membrane peptides and can adopt various conformations in
different solvents (for a review, see Killian, 1992). Grami-
cidin A is a 15-amino-acid peptide of the sequence HCO-
L-Val1-Gly2-L-Ala3-D-Leu4-L-Ala5-D-Val6-L-Val7-D-Val8-L-
Trp9-D-Leu10-L-Trp11-D-Leu12-L-Trp13-D-Leu14-L-Trp15-
NHCH2CH2OH. When incorporated into lipid membranes,
gA forms monovalent cation channels in the form of a
right-handed, single-stranded 6.3 helical dimer. In sodium
dodecyl sulfate (SDS) micelles, the secondary structure of
gA is the same as that of the channel. The 3-D structures of
gA in both SDS micelles and lipid bilayers have been
determined by NMR to atomic resolution (Arseniev et al.,
1985; Cross, 1997). In organic solvents, however, gA is
predominantly in one of the nonchannel forms. For exam-
ple, in methanol, gA occurs as an equilibrium mixture of
interwound double-helical conformers (Chen and Wallace,
1996; Veatch et al., 1974). This conformational difference
allows for analysis of the structural requirements for general
anesthetic binding in the channel.
We showed recently (Tang et al., 1999a) that the function
of the gA channel can be modulated differently by a volatile
anesthetic, 1-chloro-1,2,2-trifluorocyclobutane (F3), and a
structurally similar nonimmobilizer (nonanesthetic), 1,2-di-
chlorohexafluorocyclobutane (F6). We also showed with
2D NMR and truncated driven nuclear Overhauser effects
(Tang et al., 1999c) that while both F3 and F6 can perturb
gA residues deep inside the hydrophobic region in SDS
micelles, only F3 can interact specifically with tryptophan
residues and significantly alter the NMR resonance frequen-
cies of the tryptophan indole N-H protons near two ends of
the channel. In the present study, we determined whether
the preferred anesthetic interaction with the interfacial tryp-
tophan residues in gA was structure-dependent. The halo-
thane binding was analyzed by both 1H NMR spectroscopy
and [14C]halothane direct photoaffinity labeling techniques
for gA in the channel form in SDS and dimyristoylphos-
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phatidylcholine (DMPC) bilayers, and in the double-
stranded helical dimer form in methanol. We also attempted
to determine whether halothane binding prefers the lipid-
protein interface, by varying the gA-DMPC ratio. If halo-
thane prefers to localize at the protein-lipid interface, nor-
malized labeling of lipid will depend on protein
concentration.
The experimental methods used in this study are comple-
mentary to each other. The NMR experiments focus on the
changes in the gA channels due to anesthetic binding,
whereas the photolabeling measurements focus on the an-
esthetic halothane. The former offers the advantage of mea-
suring anesthetic-protein interaction at equilibrium without
perturbing the measured system, whereas the latter, al-
though destructive, can pinpoint the actual location at which
the interaction takes place. The combination of the two
approaches provides unambiguous assignment of the anes-
thetic binding sites at high resolution.
MATERIALS AND METHODS
Materials
Purified gA was purchased from Calbiochem (La Jolla, CA). Deuterated
sodium dodecyl sulfate (SDS-d25) and deuterated methanol were obtained
from Cambridge Isotope Laboratories (Andover, MA). Halothane was
purchased from Ayerst Laboratories (Philadelphia, PA). [14C]Halothane
([1-14C]2-bromo-2-chloro-1,1,1-trifluoroethane; 6.6 mCi/mmol) was pur-
chased from Dupont NEN as the neat compound. DMPC was purchased
from Avanti Polar Lipids (Alabaster, AL). 3-Trimethylsiyl-1-propane-
sulfuric acid (DSS) and other chemicals, of analytical grade, were from
Sigma Co. (St. Louis, MO). SDS was recrystallized in ethanol before use.
All other compounds were used without further purification.
NMR
Samples for NMR experiments were prepared in two different groups: 1)
4 mM gA dissolved in deuterated methanol (90% MeOH, 10% H2O) and
2) 2.5 mM gA in 500 mM SDS micelles dissolved in 90% H2O and 10%
D2O. To ensure a channel conformation for gA in SDS micelles, the same
preparation procedure as described previously (Tang et al., 1999c) was
followed. For both groups, 1 mM DSS was added to each sample as a
reference for 1H resonant frequencies. The pH was adjusted to 4.8, and the
solution volume was 0.5 ml in a 5-mm high-precision NMR tube, which
was later sealed, leaving a 2-ml vapor space above the solution.
Halothane was titrated directly into the samples in the NMR tube, using
a Hamilton microsyringe. After equilibrating with the vapor phase, the total
halothane concentrations in the sample solution were estimated using 19F
NMR, with reference to an external standard of 0.19 mM trifluoroacetic
acid (TFA) in a 10-mm NMR tube, which was coaxial to the 5-mm sample
tube.
The NMR experiments were conducted at 30°C, using an Otsuka-
Chemagnetics (Fort Collins, CO) CMXW-400SLI spectrometer equipped
with a 1H detection probe (Nalorac Co., Martinez, CA). The resonance
frequency for 1H was 401.102 MHz. Typical experimental parameters were
12-s 90° pulses, 1.5-s repetition delays, a 6.67-kHz spectral width, and
WATERGATE (Piotto et al., 1992) for water suppression. For each spec-
trum, 128 scans were accumulated in 4096 complex points. The data were
zero-filled once before Fourier transformation. Resonance frequencies (i.e.,
chemical shifts) were determined by multipeak Lorentzian curve fitting,
using the Origin 6.0 analysis program (Microcal Software, Northampton,
MA), and averaged among four repeated measurements.
Photolabeling
Gramicidin A was dissolved in trifluoroethanol along with DMPC in a
1:100 mole ratio, dried with argon, and exposed to high vacuum overnight.
The dried protein-lipid mixture was resuspended (1 mg/ml) in argon-
equilibrated, 50 mM potassium phosphate buffer (pH 7.0) by vigorously
mixing and sonication until the mixture was opalescent. [14C]Halothane
was added to a concentration of 0.3 mM (1% gas v/v at 37°C). The
mixture was then exposed to a 254-nm light from a pencil calibration
Hg(Ar) lamp driven at 18 mA (Oriel, Stratford, CT) for 60 s at a distance
of 5 mm in capped quartz cuvettes (1  0.5  4 cm3). The solution was
lyophilized and resuspended in methanol. The components were separated
on a C4 column with a methanol mobile phase. The gA fraction was
desformylated with methanolic 0.4 N HCl for 1 h and then sequenced on
an Applied Biosystems sequencer (model 473A; Applied Biosystems,
Norwalk, CT). Small aliquots were run to ensure proper identity of the
residues. Thereafter, larger fractions (10 nmol) were run and pre-HPLC
fractions were collected to determine the release of radioactivity by liquid
scintillation.
Lipid-protein photolabeling
To determine the possibility of preferential localization of halothane bind-
ing at the lipid-protein interface, photolabeling was measured with a
varying mole ratio of gA to DMPC, ranging from 0 to 0.05. Labeling was
carried out as above, but with 50 M 14C-halothane (0.2% gas v/v at
37°C). The DMPC was separated from the gA by thin-layer chromatogra-
phy. The radioactivity (in units of disintegrations per minute or dpm)
incorporated into each fraction was normalized to either mole phosphorus
or to microgram of protein. An aliquot of labeled lipid was hydrolyzed at
the carbonyl oxygen, using mild alkaline conditions and heat. The radio-
activity in each phase of the extraction was determined using liquid
scintillation.
RESULTS
Changes in NMR frequency of gA due to anesthetics are
indicative of anesthetic-gA interaction. We found that the
effects of halothane on the resonance frequencies of the
indole amide protons of gA were strongly dependent on gA
conformation. Fig. 1 depicts representative 1H-NMR spec-
tra in the indole amide proton region of gA in SDS micelles
and methanol (90% methanol and 10% H2O) before and
after the addition of 16 mM halothane, with frequencies
referenced to the internal standard of DSS at 0 ppm.. Similar
spectra were also acquired at other concentrations of halo-
thane. The spectral assignment was made based on 2D 1H
NOESY experiments (Tang et al., 1999c) and H-D ex-
change experiments (Tang et al., 1999b). Comparable to our
previous findings with F3 (Tang et al., 1999c), the only gA
resonance frequencies that were significantly affected were
those of the indole amide protons. Fig. 2 compares the
chemical shift changes of the indole amide protons as a
function of halothane concentration in SDS and methanol.
Solid lines are linear least-squares fit to the data. In SDS
micelles, in which gA forms 6.3 channel dimers, all of the
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indole N-H protons were shifted by halothane in a concen-
tration-dependent manner. The extent of the shifts corre-
lated with the location of the indole N-H protons along the
gramicidin channel. W9, which is located furthest from the
surface, showed the largest shift, as depicted in Fig. 2 A. In
contrast, the anesthetic effect on resonance frequency is
undetectable for gA in the form of double-stranded dimers
in methanol. The slopes in Fig. 2 B are essentially not
significantly different from zero.
Fig. 3 demonstrates the results of [14C]halothane photo-
labeling of gA in DMPC bilayers and methanol. Consistent
with NMR frequency change in SDS, the majority of halo-
thane label in gA in DMPC bilayers was found on the
tryptophan residues near the two ends of the channel. The
amount of labeling on W9, W11, W13, and W15 followed
the same trend as the anesthetic effect on indole N-H
chemical shifts: W9 showed the most labeling, whereas
W15 showed the least labeling among the four tryptophan
residues. Only the background dpm levels were observed
for residues from the N-terminus to V8. Photolabeling un-
der identical conditions in methanol showed a large reduc-
tion of incorporated dpm, but a small preference for labeling
W9 was still noted. This residual preference might be due to
persistent structure in this region of the peptide, as photo-
chemical selectivity for the tryptophan residues should have
been apparent in the other tryptophan residues as well.
Fig. 4 shows that the stoichiometry of labeling was 40
nmol labeled halothane per mol of gramicidin A, or a
halothane-gA ratio of 1:25 at a [14C]halothane concentra-
tion of 0.05 mM. The stoichiometry of labeling was
FIGURE 3 Disintegrations per minute (dpm) per cycle for each cycle of
the HPLC fractions are plotted from microsequencing of gA in DMPC (F)
and in methanol (E). All standard error bars are included for gA in DMPC,
but some are smaller than the size of the symbols. Letters denote amino
acids.
FIGURE 1 Stacked plots of 1H-NMR spectra of the indole N-H proton
region acquired at 30°C before (bottom traces) and after addition of 16 mM
halothane. (A) 2.5 mM gA in 500 mM SDS micelles. (B) 4 mM gA in
deuterated methanol (90% MeOH, 10% H2O). All resonant frequencies are
referenced to the DSS peak at 0 ppm.
FIGURE 2 Comparison of resonant frequencies of gramicidin indole
amide protons as a function of halothane concentrations in (A) SDS
micelles and (B) methanol. Resonant frequencies are determined by re-
peated measurements, using multiple-peak Lorentzian fitting. Error bars
are smaller than the size of the symbols.
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independent of gramicidin concentration in the lipid. Label-
ing of DMPC, although of much lower stoichiometry, was
strongly dependent on the mole ratio of gA to DMPC.
Furthermore, hydrolysis of the phospholipid revealed that
91% of the dpm was associated with the acyl chain region.
DISCUSSION
The strong dependence of indole amide proton frequencies
on halothane concentration indicates that structurally selec-
tive interaction between gA and the anesthetic occurs near
the tryptophan residues in the channel form. The predomi-
nant photolabeling of [14C]halothane on the tryptophan res-
idues of the channel further rules out the possibility that
NMR frequency change is caused by the nonspecific per-
turbation of the SDS or DMPC lipids surrounding the chan-
nel. Both NMR and photolabeling results suggest that the
anesthetic-gA channel interaction is strongest at or near W9
and decreases gradually in the order of W11  W13 
W15. The selective anesthetic interaction with the trypto-
phan residues diminishes almost completely when gA be-
comes double-stranded helical dimers in methanol. The
halothane photolabeling on gA in methanol falls within the
background labeling level, and halothane at sufficiently
high concentrations fails to produce a significant change in
the NMR frequencies of gA. These results imply that tryp-
tophan residues per se are not the sole determinant of the
anesthetic-gA interaction, but that the structural arrange-
ment of the tryptophan side chains in the channel conformer
might also play a role in creating the specific anesthetic
target sites.
Fig. 5 depicts the structure of gA channel in DMPC
(Ketchem et al., 1993) and the structure of gA crystal grown
from methanol (Langs et al., 1991; Burkhart et al., 1998).
Both were drawn using the RasMol program (Sayle and
Milner-White, 1995), based on the coordinates deposited at
the Protein Data Bank. Careful examination of Fig. 5 A (i.e.,
the structure for photolabeling) reveals that the tryptophan
side chains in DMPC are uniquely oriented relative to the
lipid-water interface. In particular, W9 and W15 side chains
are arranged such that an amphiphilic pocket is created in
the space between the side chains and the lipid headgroups.
Although W9 and W15 do not stack in gA in SDS (Arseniev
et al., 1985), the side chain association with the lipid head-
groups is similar. We showed previously (Xu and Tang,
FIGURE 4 The stoichiometry of 14C-halothane labeling to gA (F) and to
DMPC (E) as a function of mole ratio of gA to DMPC.
FIGURE 5 Ribbon structures of gA. (A) gA in
DMPC; the 6.3 head-to-head dimer forms a
channel across the membrane. Notice the unique
orientation of the tryptophan side chains. The co-
ordinates are from the Protein Data Bank file
1MAG. (B) gA in methanol; the coordinates are
from 1ALX.
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1997; Xu et al., 1998; Tang et al., 1997) that anesthetics are
in rapid exchange among different sites within the lipid
bilayers, with a certain preference for the amphiphilic re-
gions. The photolabeling shown in Fig. 3 suggests that in
the case of the gA channel, the specific targeting effects are
such that only the four tryptophans at the interface are
significantly labeled. Although photochemical selectivity
for aromatics is well known, the previously demonstrated
ability of halothane to photolabel other residues (Eckenhoff,
1996; Johansson and Eckenhoff, 1996), combined with the
consistent NMR evidence of this study, suggests that adduct
position is reliably reporting sites of equilibrium binding.
The structural arrangement of W9 and W15 side chains
relative to the membrane interface may also explain why the
W9 chemical shift is affected the most by the anesthetics.
The adjacent locations of W9 and W15 indole rings might
hinder the water interaction with W9. This hindrance is
conceivably reduced by the amphiphilic anesthetic mole-
cules that might facilitate the coupling between the W9
indole side chain and the water molecules that penetrate the
lipid headgroup. Indeed, we found recently (Tang et al.,
1999b), with gA in SDS and D2O, that the H-D exchange
rate of indole amide protons with water can be modulated
by volatile anesthetics.
The lack of an anisotropic environment allows gramicidin
to adopt double-helical conformations in methanol. Al-
though only a left-handed antiparallel double helix is shown
in Fig. 5 B, other types of double helices of gramicidin are
also possible in methanol in the absence of ions. Why are
the tryptophan residues of gramicidin in these double heli-
ces not as favorable sites for halothane binding as those in
the channel form (Fig. 5 A)? In addition to the structural
difference, at least two factors may be important. First, W9,
W11, and W13 in the channel form are located in the
amphiphilic regions of lipid, whereas all tryptophan resi-
dues in double helices are exposed to an isotropic solvent
phase. Because of halothane’s preferential distribution to
amphiphilic environments, the probability of finding halo-
thane molecules adjacent to the tryptophan residues is in-
creased. Consistent with this is the finding that over 90% of
the halothane adducts are found below the carbonyl oxygen,
where W9–W13 are thought to reside. Moreover, the inter-
face between gA and lipid might also help to immobilize
halothane, increasing the photolabeling affinity at the pro-
tein-lipid interface. Indeed, as shown in Fig. 4, the incor-
poration of dpm on gA remained constant but that on lipid
increased with an increasing gA-lipid ratio. The additional
incorporation into the lipid can be attributed to more inter-
facial region at higher gA-lipid ratios. In contrast, the halo-
thane distribution in methanol has no preference, reducing
the probability that halothane targets specific sites in gA.
Second, methanol molecules may compete with halothane
for binding sites. Hydrogen bonding between the tryptophan
and solvent molecules was observed for seven of eight
tryptophan residues in the methanol complex in a recent
study (Burkhart et al., 1998). A structure favoring isotropic
association with the solvent may reduce the chance of
selective interaction at a particular site.
Although leucine residues L10, L12, and L14 are also
located near the lipid interface, our NMR and photolabeling
data indicate that the anesthetic binding to these so-called
spacer residues (Jude et al., 1999) is weaker. This suggests
that anesthetic interaction with gA is controlled not only by
the preferential anesthetic distribution to the interfacial re-
gion. Preferential selection of different residues within a
given structure also plays a critical role in anesthetic-protein
interaction. The difference in anesthetic binding capacity to
leucine and tryptophan residues might be attributed to a
weak cation- type of interaction (Cubero et al., 1998). It
has been suggested that the aromatic residues in proteins,
particularly tryptophan, constitute attractive cation-binding
sites because of the intense region of negative electrostatic
potential. Most anesthetic molecules, particularly haloge-
nated ones, undergo either permanent or inducible displace-
ment of partial atomic charges (Eckenhoff and Johansson,
1997; Trudell and Bertaccini, 1998). The positive moiety of
the partial atomic charge acts as a partial cation that inter-
acts with the -current of the indole ring. A recent study of
halothane binding in a specifically designed anesthetic bind-
ing pocket also suggests the preferential interaction between
halothane and aromatic side chains (Johansson et al., 1998).
Although gA plays no role in clinical anesthesia, it serves
as a reasonable model of a transmembrane helix to test
popular hypotheses about where volatile anesthetics may
interact with ion channel proteins. Site-directed mutagene-
sis experiments have implied that sites of anesthetic inter-
action with the postsynaptic ligand-gated ion channels may
locate within the channel pore (Forman et al., 1995) or at a
putative pocket between TM2 and TM3 domains (Mihic et
al., 1997). In the case of gA, our results seem to favor the
idea that the sites of anesthetic interaction are at the lipid-
protein interface. The significant modulation of the W9
frequency by anesthetics and abundant labeling of halothane
at W9 further narrow the location to the region between the
methyl groups and headgroups. Heterogeneous anesthetic
interaction in this region has been suggested to alter the
lateral pressure of the membrane, thereby changing the
function of transmembrane channels (Cantor, 1997).
Although the halothane concentrations used for photola-
beling are comparable to the clinical values, those for the
NMR experiments cover 0–4 times the clinical range. The
halothane partition coefficient in SDS solution depends on
SDS concentrations. For 500 mM SDS used for NMR
experiments, the SDS500/gas partition coefficient of halo-
thane is 10.9 (unpublished data). Given the halothane saline/
gas partition coefficient of 1.2 (Firestone et al., 1986), it can
be estimated that the equivalent halothane concentration in
saline ranges from 0 to 2.2 mM.
In summary, both high-resolution NMR and direct pho-
toaffinity labeling measurements revealed that volatile an-
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esthetics interact specifically with the tryptophan residues
of gA in the channel conformation. This interaction largely
disappears when gA becomes double-stranded helical
dimers, suggesting that a specific structural motif is required
for anesthetic-channel interaction. This motif, when com-
bined with the lipid interface, creates an amphiphilic envi-
ronment that is preferred by the anesthetics. Tryptophan
residues in an amphiphilic environment, with their promi-
nent ring current for a cation- type of interaction, may
provide an electrostatic contact for anesthetic binding. Our
finding that a specific side-chain conformation of the chan-
nel near the membrane interface is required for anesthetic
binding may be relevant to the function of anesthetic-sen-
sitive neuronal receptor channels.
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